Ernst, M.S.; Lysack, J.T.; Hyrcza, M.D.; Chandarana, S.P.; Hao, D.
TRK Inhibition with Entrectinib in Metastatic Salivary Secretory Carcinoma (SC): A Case Report. Curr. Oncol. 2022, 29, 3933-3939.
https://doi.org/10.3390/curroncol29060314
AMA Style
Ernst MS, Lysack JT, Hyrcza MD, Chandarana SP, Hao D.
TRK Inhibition with Entrectinib in Metastatic Salivary Secretory Carcinoma (SC): A Case Report. Current Oncology. 2022; 29(6):3933-3939.
https://doi.org/10.3390/curroncol29060314
Chicago/Turabian Style
Ernst, Matthew S., John T. Lysack, Martin D. Hyrcza, Shamir P. Chandarana, and Desiree Hao.
2022. "TRK Inhibition with Entrectinib in Metastatic Salivary Secretory Carcinoma (SC): A Case Report" Current Oncology 29, no. 6: 3933-3939.
https://doi.org/10.3390/curroncol29060314
APA Style
Ernst, M. S., Lysack, J. T., Hyrcza, M. D., Chandarana, S. P., & Hao, D.
(2022). TRK Inhibition with Entrectinib in Metastatic Salivary Secretory Carcinoma (SC): A Case Report. Current Oncology, 29(6), 3933-3939.
https://doi.org/10.3390/curroncol29060314